TG Manufacturing acquires contract manufacturing firm TurnKey
Category: #business  By Nikita Chaurasia  Date: 2019-09-10
  • share
  • Twitter
  • Facebook
  • LinkedIn

TG Manufacturing acquires contract manufacturing firm TurnKey
  • TurnKey presently supplies a varied group of consumers in the industrial laboratory, defense and gaming industries among others.
  • Using TGM’s advanced manufacturing technology, quality systems and global network and combining them with TurnKey’s access to new markets and process capabilities would build a stronger organization.

TG Manufacturing, a diverse, fully-integrated metals manufacturing firm based in Western Michigan and a subsidiary of Tiger Industrial Systems, reportedly announced the acquisition of TurnKey Fabrication, a certified contract manufactures that provides engineering and sheet metal fabrication services.

TurnKey Fabrication is based in Grand Rapids and operates with laser, CNC brake press, machining, auto feed laser, welding and assembly process capability. The company is headquartered in and operates out of a 55,000 sq. ft. facility in Grand Rapids, Michigan. TurnKey presently supplies a varied group of consumers in the industrial laboratory, defense and gaming industries among others.

Rich Achtenberg, Chief Executive Officer of TG Manufacturing stated that TG Manufacturing will continue the operations currently run by TurnKey Fabrication. Additionally, TurnKey will become a Craft Steel operations division of TGM in Byron Center.

Rich added that TurnKey will help the company in expanding both markets and capacity of the company’s metal fabrication division. The synergies created by Craft Steel-TurnKey integration will enable TG Manufacturing to achieve a more rapid and responsive turnaround to address customer demands. Achtenberg further stated that the company’s continued drive towards vertical process integration is enhanced greatly through TurnKey’s acquisition.

Les Onan, CEO at TurnKey Fabrication stated that this acquisition supports the expansion of TG Manufacturing and further expands the process capabilities for both the companies. Les further added that TurnKey Fabrication will be focusing on its assembly and integration of electrical gaming products while its fabrication will be outsourced to TG Manufacturing.

Neither TG Manufacturing, not TurnKey Fabrication have unveiled any financial terms pertaining to the proposed acquisition of TurnKey yet.

Source Credit: http://tg-manufacturing.com/tg-manufacturing-acquires-turnkey-fabrication/

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia    

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More

More News By Nikita Chaurasia

Trump calls for a $2 trillion budget for U.S. infrastructure growth
Trump calls for a $2 trillion budget for U.S. infrastructure growth
By Nikita Chaurasia

U.S. President Donald Trump has reportedly called for a $2 trillion spending budget to repair the and build new and currently crumbling infrastructure including tunnels, bridges, and roads, seizing on the COVID-19 outbreak as well as interest rates t...

Analytics 4 Life reveals new data backing novel method to predict LVEDP
Analytics 4 Life reveals new data backing novel method to predict LVEDP
By Nikita Chaurasia

Analytics 4 Life, one the leading digital health company committed to improving existing diagnostic pathways, has reportedly presented data on its heart failure research at the ACC’s (American College of Cardiology) 69th Annual Scientific Sessi...

Esperion presents pooled analyses of NEXLETOL & NEXLIZET at ACC.20/WCC
Esperion presents pooled analyses of NEXLETOL & NEXLIZET at ACC.20/WCC
By Nikita Chaurasia

Esperion Therapeutics, a US-based public pharmaceutical company, reportedly unveiled that two pooled data analyses from its 4 Phase 3 clinical studies of NEXLETOL and outcomes from Phase 2 trial of NEXLIZET were showcased during the ACC.20/WCC. In a...